Tech Company Financing Transactions
Biograil Funding Round
Biograil secured a $22.5 million funding round on 11/4/2026. Investors included Verve Ventures and High-Tech Gründerfonds.
Transaction Overview
Company Name
Announced On
11/4/2026
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Undisclosed
Investors
Verve Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance preparations for Phase 1 clinical testing of its BIONDD® technology, supporting key milestones including non-clinical GLP studies and the establishment of a manufacturing GMP process.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Langebjerg 1
Roskilde, 4000
Denmark
Roskilde, 4000
Denmark
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Biograil� was established in 2019 and is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD® technology to unlock the potential of transforming markets of injectable pharmaceutical products into convenient oral capsules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karsten Lindhardt
Chief Operating Officer
Nils Piwon
Chief Scientific Officer
Nikolaj Skak
Chief Technical Officer
Morten Frederiksen
VP - Finance
Kasper Rolsted
VP - Manufacturing
Alex Linnemann
VP - Manufacturing
Martin Olsen
VP - R & D
Anne Larsen
VP - Regulatory Affairs
Lene Havsteen
VP - Regulatory Affairs
Michael Tranekjer
Browse more venture capital transactions:
Prev: 11/4/2026: Supa venture capital transaction
Next: 11/4/2026: Kinewell Energy venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs